Background Mycoplasma genitalium is now recognised as an important bacterial sexually
transmitted infection. We summarised data from studies of mutations associated with …

Mycoplasma genitalium infection contributes to 10–35% of non‐chlamydial non‐gonococcal
urethritis in men. In women, M. genitalium is associated with cervicitis and pelvic …

Mycoplasma genitalium infection contributes to 10–35% of non‐chlamydial non‐gonococcal
urethritis in men. In women, M. genitalium is associated with cervicitis and pelvic …

The history, replication, genetics, characteristics (both biological and physical), and factors
involved in the pathogenesis of Mycoplasma genitalium are presented. The latter factors …

The emergence of antimicrobial resistance (AMR) is a major concern worldwide and already
compromises treatment effectiveness and control of several bacterial sexually transmitted …

Background Rising macrolide and quinolone resistance in Mycoplasma genitalium
necessitate new treatment approaches. We evaluated outcomes of sequential antimicrobial …

Macrolide resistance mechanisms can be target-based with a change in a 23S ribosomal
RNA (rRNA) residue or a mutation in ribosomal protein L4 or L22 affecting the ribosome's …

Sexually transmitted infections (STIs) have been part of human life since ancient times, and
their symptoms affect quality of life, and sequelae are common. Socioeconomic and …

Background. Our aim was to determine the efficacy of 1 g azithromycin and alternative
antibiotic regimens in a prospective cohort of Mycoplasma genitalium–infected participants …

Background. Azithromycin or doxycycline is recommended for nongonococcal urethritis
(NGU); recent evidence suggests their efficacy has declined. We compared azithromycin …